Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2026-02-06 00:00:00 ET · period of report 2026-02-04 · accession 0001793412-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-04 | TSHA | Alam Kamran | CFO | S - Sale | $4.52 | -1,655 | 1.44M | -0.1% | -$7,481 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-04 | S | D | 1,655 | $4.52 | 1,442,131 | D | — | — | (F1) The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. |